Orchid Delays Release of 2004 10-K Due to December Departure of CFO Spicer | GenomeWeb

NEW YORK, March 18 (GenomeWeb News) - Orchid Biosciences has delayed the release of its 10-K 2004 earnings report due to the recent departure of CFO Mike Spicer, and because the SEC now considers Orchid to be an accelerated filer, the company said in a document filed with the SEC yesterday.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.